The Search for New Anti-Cancer Drugs

Dr. Claude Labrie (2001, 2002 and 2005 Research Grants)

Cancer cells are good at surviving, partially because of their ability to adapt to stress. Dr. Labrie’s lab has shown that the protein AIbZIP, which is found in high numbers in prostate cancer cells, helps cancer cells adapt to stress. He and his team have created peptides that can prevent AIbZIP from doing its job – which could ultimately cause the death of the cells. He is now testing the ability of these peptides to infiltrate cancer cells and cause cancer cell death. The long term goal of this research is to turn these cancer cell killing peptides into new anticancer drugs.




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.
More

12 innovative Canadian prostate cancer researchers set out to make new Discoveries

Toronto, ON – September 28, 2017: 12 forward-thinking Canadian prostate cancer researchers have been rewarded for their innovation with Movember Discovery Grants.
More

Gray Tools '2017 Together We Are Stronger' campaign a success in creating awareness and raising funds for prostate cancer

BRAMPTON, Ontario, Sept 26, 2017 (GLOBE NEWSWIRE) -- Gray Tools Canada Inc, in cooperation with Prostate Cancer Canada, is proud to announce that its “2017 Together We Are Stronger” initiative raised $4,000, which will go directly towards funding valuable research that is needed to improve the way we diagnose, treat, and support men living with the disease.
More


Click here for news archive